Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244429997> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4244429997 endingPage "8" @default.
- W4244429997 startingPage "4" @default.
- W4244429997 abstract "The adjuvant treatment of colon cancer is now accepted as an effective therapy following surgical resection of the primary tumor in patients at high risk for relapse. Results of studies conducted in the last 10 years have confirmed the benefits of using various 5-fluorouracil (5-FU)-based chemotherapy regimens to decrease recurrence rates and improve patient survival. The North Central Cancer Treatment Group-Mayo Clinic studies have made a significant contribution to establishing the role of adjuvant therapy in colon cancer. Our first study to suggest the effectiveness of adjuvant chemotherapy in patients with stage III disease was reported in 1989. The study used a combination of 5-FU and the anthelminthic agent levamisole, tested because of its ability to positively modulate the human cellular immune system. The results of this study were confirmed by a larger Intergroup study (0035) showing significant decreases in relapse and death rates in stage III colon cancer patients treated with 5-FU plus levamisole compared with surgery alone. Clinical trials conducted throughout the 1990s tested various 5-FU based regimens against the standard 5-FU and levamisole combination. From these trials, the combination of 5-FU plus leucovorin emerged as the standard surgical adjuvant treatment of colon cancer. The efficacy of treatment with this regimen for 6 months was similar to that of a 1-year 5-FU plus levamisole regimen. These findings led to the design of trials in which 5-FU was combined with both leucovorin and levamisole. No differences in efficacy were found in any of the various combinations tested. Current clinical trials are investigating the use of newer agents such as CPT-II in the adjuvant setting. The results of these trials may further improve the efficacy of adjuvant therapy in patients with high-risk colon cancer." @default.
- W4244429997 created "2022-05-12" @default.
- W4244429997 creator A5062302578 @default.
- W4244429997 date "2001-02-01" @default.
- W4244429997 modified "2023-10-15" @default.
- W4244429997 title "North Central Cancer Treatment Group[mdash ]Mayo Clinic trials in colon cancer" @default.
- W4244429997 doi "https://doi.org/10.1053/sonc.2001.19721" @default.
- W4244429997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11273589" @default.
- W4244429997 hasPublicationYear "2001" @default.
- W4244429997 type Work @default.
- W4244429997 citedByCount "0" @default.
- W4244429997 crossrefType "journal-article" @default.
- W4244429997 hasAuthorship W4244429997A5062302578 @default.
- W4244429997 hasConcept C121608353 @default.
- W4244429997 hasConcept C126322002 @default.
- W4244429997 hasConcept C141071460 @default.
- W4244429997 hasConcept C143998085 @default.
- W4244429997 hasConcept C2776694085 @default.
- W4244429997 hasConcept C2777863537 @default.
- W4244429997 hasConcept C2777982462 @default.
- W4244429997 hasConcept C2781325985 @default.
- W4244429997 hasConcept C2781413609 @default.
- W4244429997 hasConcept C526805850 @default.
- W4244429997 hasConcept C535046627 @default.
- W4244429997 hasConcept C71924100 @default.
- W4244429997 hasConcept C90924648 @default.
- W4244429997 hasConceptScore W4244429997C121608353 @default.
- W4244429997 hasConceptScore W4244429997C126322002 @default.
- W4244429997 hasConceptScore W4244429997C141071460 @default.
- W4244429997 hasConceptScore W4244429997C143998085 @default.
- W4244429997 hasConceptScore W4244429997C2776694085 @default.
- W4244429997 hasConceptScore W4244429997C2777863537 @default.
- W4244429997 hasConceptScore W4244429997C2777982462 @default.
- W4244429997 hasConceptScore W4244429997C2781325985 @default.
- W4244429997 hasConceptScore W4244429997C2781413609 @default.
- W4244429997 hasConceptScore W4244429997C526805850 @default.
- W4244429997 hasConceptScore W4244429997C535046627 @default.
- W4244429997 hasConceptScore W4244429997C71924100 @default.
- W4244429997 hasConceptScore W4244429997C90924648 @default.
- W4244429997 hasIssue "1B" @default.
- W4244429997 hasLocation W42444299971 @default.
- W4244429997 hasLocation W42444299972 @default.
- W4244429997 hasOpenAccess W4244429997 @default.
- W4244429997 hasPrimaryLocation W42444299971 @default.
- W4244429997 hasRelatedWork W1984282923 @default.
- W4244429997 hasRelatedWork W2054423421 @default.
- W4244429997 hasRelatedWork W2091720821 @default.
- W4244429997 hasRelatedWork W2373226427 @default.
- W4244429997 hasRelatedWork W2387456186 @default.
- W4244429997 hasRelatedWork W2388730008 @default.
- W4244429997 hasRelatedWork W2465617904 @default.
- W4244429997 hasRelatedWork W3179015302 @default.
- W4244429997 hasRelatedWork W4300185351 @default.
- W4244429997 hasRelatedWork W757206253 @default.
- W4244429997 hasVolume "28" @default.
- W4244429997 isParatext "false" @default.
- W4244429997 isRetracted "false" @default.
- W4244429997 workType "article" @default.